Adam K. Simpson - Jan 22, 2024 Form 4 Insider Report for Icosavax, Inc. (ICVX)

Role
Chief Executive Officer, Director
Signature
/s/ Elizabeth Bekiroglu, Attorney-in-Fact
Stock symbol
ICVX
Transactions as of
Jan 22, 2024
Transactions value $
$100,979
Form type
4
Date filed
1/23/2024, 06:15 PM
Previous filing
Jan 4, 2024
Next filing
Feb 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICVX Common Stock Options Exercise $4.02K +4.79K +1.84% $0.84* 265K Jan 22, 2024 Direct
transaction ICVX Common Stock Options Exercise $97K +93.2K +35.12% $1.04* 359K Jan 22, 2024 Direct
holding ICVX Common Stock 532K Jan 22, 2024 By family trust
holding ICVX Common Stock 129K Jan 22, 2024 By family trust
holding ICVX Common Stock 129K Jan 22, 2024 By family trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICVX Stock Option (Right to Buy) Options Exercise $0 -4.79K -100% $0.00* 0 Jan 22, 2024 Common Stock 4.79K $0.84 Direct F1
transaction ICVX Stock Option (Right to Buy) Options Exercise $0 -93.2K -31.11% $0.00 206K Jan 22, 2024 Common Stock 93.2K $1.04 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vested on February 21, 2021, and 1/48th of the shares subject to the option vest monthly thereafter.
F2 25% of the shares subject to the option vested on January 14, 2022, and 1/48th of the shares subject to the option vest monthly thereafter.